Adenosine (Ado), a smooth muscle vasodilator and modulator of cardiac funct
ion, is taken up by many cell types via a saturable transporter, blockable
by dipyridamole. To quantitate the influences of endothelial cells in gover
ning the blood-tissue exchange of Ado and its concentration in the intersti
tial fluid, one must define the permeability-surface area products (PS) for
Ado via passive transport through interendothelial gaps [PSg (Ado)] and ac
ross the endothelial cell luminal membrane (PSecl) in their normal in vivo
setting. With the use of the multiple-indicator dilution (MID) technique in
Krebs-Ringer perfused, isolated guinea pig hearts (preserving endothelial
myocyte geometry) and by separating Ado metabolites by HPLC, we found perme
ability-surface area products for an extracellular solute, sucrose, via pas
sive transport through interendothelial gaps [PSg (Suc)] to be 1.9 +/- 0.6
ml . g(-1) . min(-1) (n = 16 MID curves in 4 hearts) and took PSg (Ado) to
be 1.2 times PSg (Suc). MID curves were obtained with background nontracer
Ado concentrations up to 800 mu m, partially saturating the transporter and
reducing its effective PSecl for Ado. The estimated maximum value for PSec
l in the absence of background adenosine was 1.1 +/- 0.1 ml . g(-1) . min(-
1) [maximum rate of transporter conformational change to move the substrate
from one side of the membrane to the other (maximal velocity; V-max) times
surface area of 125 +/- 11 nmol . g(-1) . min(-1)], and the Michaelis-Ment
en constant (K-m) was 114 +/- 12 mu M, where +/- indicates 95% confidence l
imits. Physiologically, only high Ado release with hypoxia or ischemia will
partially saturate the transporter.